Led by Julie Taguchi, MD as the principal investigator, WHN has obtained IRB approval for a study titled “A New Hormone Replacement Paradigm.”
This study aims to investigate the health impacts of Physiologic Hormone Restoration Therapy™ in comparison to the use of estradiol patch and cyclical oral progesterone in 210 women over a three-year period. The Physiologic HRT arm of the study will involve transdermal application of estradiol and progesterone at various doses to mimic natural hormone rhythms throughout a menstrual cycle. The primary objective of the study is to assess improvement in bone density over the three-year period, while secondary objectives include evaluating changes in participants’ quality of life, anxiety, depression, cognition, menopause symptoms, and insulin and cardiac markers.
WHN is currently in the process of raising funds for this clinical study and will provide updates on the progress of this significant endeavor. For more information on the study, please visit the official clinical trial web page.
Interested in learning more about the Physiologic Hormone Restoration Program? Get started by enrolling in WHN’s FREE Physiologic HRT Training and Coaching Program.
Every person’s body is different. There are many genetic, health and lifestyle factors to consider for hormone restoration. It’s important to work with a practitioner you can trust.
The Mission of WHN is to expand the Standard of Care by promoting, advocating, and advancing women’s wellbeing and longevity through clinical research and education about the benefits of Physiologic Restoration™ to reduce the symptoms of hormone imbalance, chronic disease and degenerative decline.
WHN is a registered 501(c)3 not-for-profit corporation